Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium ... Doctors prescribe losartan for patients with high blood pressure and for Type 2 diabetics who ...

A pharmaceutical company has expanded a voluntary recall for medication used to treat hypertension as the medicine includes trace amounts of a chemical that could cause cancer. According to the ...

NEW YORK (MedscapeWire) Mar 26 — A head-to-head trial reported in the March 23 issue of The Lancet shows that losartan is better than atenolol at reducing cardiovascular disease and stroke, with ...

Losartan is an angiotensin II type 1 (AT1) receptor blocker and is considered the first line of treatment for hypertension to reduce the risk of cardiovascular events, as well as preventing heart ...

The Losartan Intervention for Endpoint reduction in hypertension (LIFE) study demonstrated the clinical benefit of losartan-based therapy in hypertensive patients with left ventricular hypertrophy ...

Thunström E, Manhem K, Yucel-Linberg T, et al. Neuroendocrine and Inflammatory Responses to Losartan and CPAP in Patients with Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial.

Another drug company has recalled a version of losartan blood pressure medication over concerns the drug contains tiny amounts of a carcinogen.. Torrent Pharmaceuticals last week recalled eight ...

Therapy with losartan compared to irbesartan was performed in a Chinese sample of hypertensive patients with elevated serum uric acid (SUA) levels. After 1 week of screening and a 2 week single ...

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient.

Scienture Holdings, Inc. announced the initiation of supply chain activities by its subsidiary, Scienture, LLC, to manufacture ArbliTM (losartan potassium) Oral Suspension in preparation for its ...